How many institutional investors hold GSK?

4 tracked institutional investors disclosed a position in GSK (GSK PLC) in their most recent 13F filing.

Who is the largest institutional holder of GSK?

Steve Cohen, Point72 Asset Management, holds the largest disclosed position in GSK, valued at $72M.

Where does this GSK ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

GSK — GSK PLC

Name: GSK PLC (GSK) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About GSK PLC (GSK)

GSK PLC (GSK) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $72M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 1 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in GSK

/100

Institutional Accumulation

Added / Increased2

Reduced1

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track GSK

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

GSK Ownership Composition

How GSK PLC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

67% of tracked value

Institutions

tracked investors

Total Reported

$218.4M

combined 13F value

Other66.9%
Hedge Funds33.1%

Other(3)

66.9%

Hedge Funds(1)

33.1%

Tracked investors reporting GSK

Investor	Firm	Shares	Market value	% of portfolio	As of
Steve Cohen	Point72 Asset Management	1.5M	$72.3M	0.08%	Dec 31, 2025
Ken Griffin	Citadel Advisors	1.3M	$70.3M	0.01%	Mar 31, 2026
Ray Dalio	Bridgewater Associates	698.7K	$38.6M	0.17%	Mar 31, 2026
Izzy Englander	Millennium Management	673.8K	$37.2M	0.02%	Mar 31, 2026

Steve CohenDec 31, 2025
Point72 Asset Management
Shares
1.5M
Value
$72.3M
% Portfolio
0.08%
Ken GriffinMar 31, 2026
Citadel Advisors
Shares
1.3M
Value
$70.3M
% Portfolio
0.01%
Ray DalioMar 31, 2026
Bridgewater Associates
Shares
698.7K
Value
$38.6M
% Portfolio
0.17%
Izzy EnglanderMar 31, 2026
Millennium Management
Shares
673.8K
Value
$37.2M
% Portfolio
0.02%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Ray Dalio	Reduced	-50.68%	$38.6M	May 15, 2026
Ray Dalio	Increased	1.05%	$69.5M	Feb 13, 2026
Ray Dalio	New	—	$60.5M	Nov 13, 2025

Ray Dalio
Reduced
$38.6M(-50.68%)May 15, 2026
Ray Dalio
Increased
$69.5M(1.05%)Feb 13, 2026
Ray Dalio
New
$60.5MNov 13, 2025

Frequently asked questions

How many institutional investors hold GSK?: 4 tracked institutional investors disclosed a position in GSK (GSK PLC) in their most recent 13F filing.
Who is the largest institutional holder of GSK?: Steve Cohen, Point72 Asset Management, holds the largest disclosed position in GSK, valued at $72M.
Did institutional ownership of GSK increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 1 reduced, and 0 fully exited GSK.
Where does this GSK ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.